GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gtf2i
|
ENSMUSG00000060261.9 | general transcription factor II I |
Gtf2f1
|
ENSMUSG00000002658.9 | general transcription factor IIF, polypeptide 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gtf2i | mm10_v2_chr5_-_134314637_134314676 | 0.53 | 1.0e-03 | Click! |
Gtf2f1 | mm10_v2_chr17_-_57011271_57011326 | 0.04 | 8.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_70679016 | 1.89 |
ENSMUST00000144537.1
|
Adam10
|
a disintegrin and metallopeptidase domain 10 |
chr15_-_66948419 | 1.82 |
ENSMUST00000167817.1
|
Ndrg1
|
N-myc downstream regulated gene 1 |
chr14_+_54640952 | 1.78 |
ENSMUST00000169818.2
|
Gm17606
|
predicted gene, 17606 |
chr5_+_43672289 | 1.69 |
ENSMUST00000156034.1
|
Cc2d2a
|
coiled-coil and C2 domain containing 2A |
chrX_+_13071470 | 1.44 |
ENSMUST00000169594.2
|
Usp9x
|
ubiquitin specific peptidase 9, X chromosome |
chr10_-_127620960 | 1.43 |
ENSMUST00000121829.1
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr17_+_26941420 | 1.37 |
ENSMUST00000081285.3
ENSMUST00000177932.1 |
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr16_-_74411776 | 1.34 |
ENSMUST00000116586.2
|
Robo2
|
roundabout homolog 2 (Drosophila) |
chr10_-_127620922 | 1.32 |
ENSMUST00000118455.1
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr4_-_43558386 | 1.30 |
ENSMUST00000130353.1
|
Tln1
|
talin 1 |
chr4_-_123527648 | 1.25 |
ENSMUST00000147228.1
|
Macf1
|
microtubule-actin crosslinking factor 1 |
chr8_+_107293500 | 1.13 |
ENSMUST00000151114.1
ENSMUST00000075922.4 ENSMUST00000125721.1 |
Nfat5
|
nuclear factor of activated T cells 5 |
chr7_+_44428938 | 1.09 |
ENSMUST00000127790.1
|
Lrrc4b
|
leucine rich repeat containing 4B |
chr13_+_99184733 | 1.08 |
ENSMUST00000056558.8
|
Zfp366
|
zinc finger protein 366 |
chr2_-_45112890 | 1.06 |
ENSMUST00000076836.6
|
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr16_+_95257646 | 1.05 |
ENSMUST00000113856.1
ENSMUST00000134166.1 ENSMUST00000125847.1 ENSMUST00000140222.1 |
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr5_-_131538687 | 1.04 |
ENSMUST00000161374.1
|
Auts2
|
autism susceptibility candidate 2 |
chr6_+_34746368 | 1.04 |
ENSMUST00000142716.1
|
Cald1
|
caldesmon 1 |
chr11_+_96282529 | 1.04 |
ENSMUST00000125410.1
|
Hoxb8
|
homeobox B8 |
chr8_-_90348126 | 0.99 |
ENSMUST00000176034.1
ENSMUST00000176616.1 |
Tox3
|
TOX high mobility group box family member 3 |
chr13_-_63565520 | 0.95 |
ENSMUST00000021921.5
|
Ptch1
|
patched homolog 1 |
chrX_-_145505175 | 0.95 |
ENSMUST00000143610.1
|
Amot
|
angiomotin |
chr2_+_18064645 | 0.94 |
ENSMUST00000114680.2
|
Mllt10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
chr11_-_69617879 | 0.94 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chr6_+_34745952 | 0.91 |
ENSMUST00000123823.1
ENSMUST00000136907.1 ENSMUST00000126181.1 |
Cald1
|
caldesmon 1 |
chr4_-_41695935 | 0.91 |
ENSMUST00000145379.1
|
Cntfr
|
ciliary neurotrophic factor receptor |
chr15_+_12117848 | 0.90 |
ENSMUST00000128475.1
ENSMUST00000134277.1 |
Zfr
|
zinc finger RNA binding protein |
chr2_+_92184106 | 0.89 |
ENSMUST00000111294.1
ENSMUST00000111293.2 ENSMUST00000162146.1 ENSMUST00000111292.1 ENSMUST00000162497.1 |
Phf21a
|
PHD finger protein 21A |
chrX_+_159255919 | 0.87 |
ENSMUST00000112492.1
|
Rps6ka3
|
ribosomal protein S6 kinase polypeptide 3 |
chr11_+_44519405 | 0.87 |
ENSMUST00000101327.2
|
Rnf145
|
ring finger protein 145 |
chrX_+_42150672 | 0.86 |
ENSMUST00000069619.7
|
Stag2
|
stromal antigen 2 |
chr16_+_95257558 | 0.85 |
ENSMUST00000113862.1
ENSMUST00000113861.1 ENSMUST00000037154.7 ENSMUST00000113854.1 ENSMUST00000113855.1 |
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr18_+_7869707 | 0.84 |
ENSMUST00000166062.1
ENSMUST00000169010.1 |
Wac
|
WW domain containing adaptor with coiled-coil |
chr16_-_91011029 | 0.84 |
ENSMUST00000130813.1
|
Synj1
|
synaptojanin 1 |
chr17_-_35703971 | 0.84 |
ENSMUST00000148065.1
|
Ddr1
|
discoidin domain receptor family, member 1 |
chr2_+_48949495 | 0.83 |
ENSMUST00000112745.1
|
Mbd5
|
methyl-CpG binding domain protein 5 |
chr2_-_38287174 | 0.82 |
ENSMUST00000130472.1
|
Dennd1a
|
DENN/MADD domain containing 1A |
chrX_+_42151002 | 0.82 |
ENSMUST00000123245.1
|
Stag2
|
stromal antigen 2 |
chr1_+_178798438 | 0.80 |
ENSMUST00000160789.1
|
Kif26b
|
kinesin family member 26B |
chr2_+_105126505 | 0.80 |
ENSMUST00000143043.1
|
Wt1
|
Wilms tumor 1 homolog |
chr2_+_74745674 | 0.79 |
ENSMUST00000140666.1
|
Hoxd3
|
homeobox D3 |
chr8_+_107293463 | 0.79 |
ENSMUST00000169453.1
|
Nfat5
|
nuclear factor of activated T cells 5 |
chr15_-_99457712 | 0.78 |
ENSMUST00000161948.1
|
Nckap5l
|
NCK-associated protein 5-like |
chrX_+_48343758 | 0.78 |
ENSMUST00000037596.6
|
Bcorl1
|
BCL6 co-repressor-like 1 |
chr4_-_44168252 | 0.78 |
ENSMUST00000145760.1
ENSMUST00000128426.1 |
Rnf38
|
ring finger protein 38 |
chr6_+_85587524 | 0.77 |
ENSMUST00000072018.5
|
Alms1
|
Alstrom syndrome 1 |
chr10_-_63244135 | 0.75 |
ENSMUST00000054837.3
|
1700120B22Rik
|
RIKEN cDNA 1700120B22 gene |
chr16_+_95258209 | 0.75 |
ENSMUST00000113858.1
|
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr6_+_38109320 | 0.75 |
ENSMUST00000031851.3
|
Tmem213
|
transmembrane protein 213 |
chr6_+_141249161 | 0.74 |
ENSMUST00000043259.7
|
Pde3a
|
phosphodiesterase 3A, cGMP inhibited |
chr7_+_25268387 | 0.73 |
ENSMUST00000169392.1
|
Cic
|
capicua homolog (Drosophila) |
chr16_-_74411292 | 0.72 |
ENSMUST00000117200.1
|
Robo2
|
roundabout homolog 2 (Drosophila) |
chr8_-_91801948 | 0.72 |
ENSMUST00000175795.1
|
Irx3
|
Iroquois related homeobox 3 (Drosophila) |
chr3_-_87174518 | 0.72 |
ENSMUST00000041732.8
|
Kirrel
|
kin of IRRE like (Drosophila) |
chr6_+_125321205 | 0.71 |
ENSMUST00000176365.1
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr6_+_92092369 | 0.70 |
ENSMUST00000113463.1
|
Nr2c2
|
nuclear receptor subfamily 2, group C, member 2 |
chr5_+_118560719 | 0.70 |
ENSMUST00000100816.4
|
Med13l
|
mediator complex subunit 13-like |
chr7_-_133123770 | 0.67 |
ENSMUST00000164896.1
ENSMUST00000171968.1 |
Ctbp2
|
C-terminal binding protein 2 |
chr4_-_126202583 | 0.66 |
ENSMUST00000106142.1
ENSMUST00000169403.1 ENSMUST00000130334.1 |
Thrap3
|
thyroid hormone receptor associated protein 3 |
chrX_+_101849375 | 0.66 |
ENSMUST00000124279.1
|
Nhsl2
|
NHS-like 2 |
chr6_-_12109583 | 0.64 |
ENSMUST00000080891.5
|
Gm6578
|
predicted gene 6578 |
chr7_+_45705088 | 0.64 |
ENSMUST00000080885.3
|
Dbp
|
D site albumin promoter binding protein |
chr16_-_42340595 | 0.64 |
ENSMUST00000102817.4
|
Gap43
|
growth associated protein 43 |
chr5_-_137116177 | 0.63 |
ENSMUST00000054384.5
ENSMUST00000152207.1 |
Trim56
|
tripartite motif-containing 56 |
chr6_-_122340200 | 0.62 |
ENSMUST00000159384.1
|
Phc1
|
polyhomeotic-like 1 (Drosophila) |
chr17_+_48462355 | 0.62 |
ENSMUST00000162132.1
|
Unc5cl
|
unc-5 homolog C (C. elegans)-like |
chr7_+_110773658 | 0.59 |
ENSMUST00000143786.1
|
Ampd3
|
adenosine monophosphate deaminase 3 |
chr5_-_44799643 | 0.58 |
ENSMUST00000070748.5
|
Ldb2
|
LIM domain binding 2 |
chr11_+_96282648 | 0.58 |
ENSMUST00000168043.1
|
Hoxb8
|
homeobox B8 |
chr15_-_8444449 | 0.57 |
ENSMUST00000052965.6
|
Nipbl
|
Nipped-B homolog (Drosophila) |
chrX_-_102252154 | 0.57 |
ENSMUST00000050551.3
|
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr5_-_124187150 | 0.57 |
ENSMUST00000161938.1
|
Pitpnm2
|
phosphatidylinositol transfer protein, membrane-associated 2 |
chr16_+_72663143 | 0.56 |
ENSMUST00000023600.7
|
Robo1
|
roundabout homolog 1 (Drosophila) |
chr8_-_91801547 | 0.56 |
ENSMUST00000093312.4
|
Irx3
|
Iroquois related homeobox 3 (Drosophila) |
chr4_-_126202335 | 0.56 |
ENSMUST00000142125.1
ENSMUST00000106141.2 |
Thrap3
|
thyroid hormone receptor associated protein 3 |
chr15_-_84447037 | 0.56 |
ENSMUST00000080751.2
|
1810041L15Rik
|
RIKEN cDNA 1810041L15 gene |
chr1_-_64121389 | 0.56 |
ENSMUST00000055001.3
|
Klf7
|
Kruppel-like factor 7 (ubiquitous) |
chr17_+_48299952 | 0.56 |
ENSMUST00000170941.1
|
Treml2
|
triggering receptor expressed on myeloid cells-like 2 |
chr6_+_4504814 | 0.55 |
ENSMUST00000141483.1
|
Col1a2
|
collagen, type I, alpha 2 |
chr17_-_85688252 | 0.55 |
ENSMUST00000024947.7
ENSMUST00000163568.2 |
Six2
|
sine oculis-related homeobox 2 |
chr6_-_148831395 | 0.55 |
ENSMUST00000145960.1
|
Ipo8
|
importin 8 |
chr4_-_83486178 | 0.55 |
ENSMUST00000130626.1
|
Psip1
|
PC4 and SFRS1 interacting protein 1 |
chr9_+_70678950 | 0.54 |
ENSMUST00000067880.6
|
Adam10
|
a disintegrin and metallopeptidase domain 10 |
chr2_+_4300462 | 0.54 |
ENSMUST00000175669.1
|
Frmd4a
|
FERM domain containing 4A |
chr11_-_79059872 | 0.54 |
ENSMUST00000141409.1
|
Ksr1
|
kinase suppressor of ras 1 |
chr6_-_38109548 | 0.54 |
ENSMUST00000114908.1
|
Atp6v0a4
|
ATPase, H+ transporting, lysosomal V0 subunit A4 |
chr12_+_8674391 | 0.54 |
ENSMUST00000163569.1
ENSMUST00000169089.1 |
Pum2
|
pumilio 2 (Drosophila) |
chr10_+_100015817 | 0.53 |
ENSMUST00000130190.1
ENSMUST00000020129.7 |
Kitl
|
kit ligand |
chr4_+_13751297 | 0.53 |
ENSMUST00000105566.2
|
Runx1t1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr7_-_78577771 | 0.53 |
ENSMUST00000039438.7
|
Ntrk3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr9_-_60522017 | 0.53 |
ENSMUST00000140824.1
|
Thsd4
|
thrombospondin, type I, domain containing 4 |
chr6_-_127151044 | 0.52 |
ENSMUST00000000188.8
|
Ccnd2
|
cyclin D2 |
chr19_+_44293676 | 0.52 |
ENSMUST00000026221.5
|
Scd2
|
stearoyl-Coenzyme A desaturase 2 |
chr10_+_81137953 | 0.52 |
ENSMUST00000117956.1
|
Zbtb7a
|
zinc finger and BTB domain containing 7a |
chr2_-_121271315 | 0.51 |
ENSMUST00000131245.1
|
Trp53bp1
|
transformation related protein 53 binding protein 1 |
chr17_+_88597663 | 0.51 |
ENSMUST00000137138.1
|
Ston1
|
stonin 1 |
chr13_+_93303757 | 0.51 |
ENSMUST00000109494.1
|
Homer1
|
homer homolog 1 (Drosophila) |
chr6_-_92481343 | 0.50 |
ENSMUST00000113445.1
|
Prickle2
|
prickle homolog 2 (Drosophila) |
chrX_+_42068398 | 0.50 |
ENSMUST00000115095.2
|
Xiap
|
X-linked inhibitor of apoptosis |
chr2_+_74681991 | 0.50 |
ENSMUST00000142312.1
|
Hoxd11
|
homeobox D11 |
chrX_-_78583782 | 0.50 |
ENSMUST00000177904.1
|
Prrg1
|
proline rich Gla (G-carboxyglutamic acid) 1 |
chr13_+_44840686 | 0.50 |
ENSMUST00000173906.1
|
Jarid2
|
jumonji, AT rich interactive domain 2 |
chr3_-_104220103 | 0.49 |
ENSMUST00000121198.1
ENSMUST00000122303.1 |
Magi3
|
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
chr1_-_166002613 | 0.49 |
ENSMUST00000177358.1
ENSMUST00000160908.1 ENSMUST00000027850.8 ENSMUST00000160260.2 |
Pou2f1
|
POU domain, class 2, transcription factor 1 |
chr12_-_118301429 | 0.49 |
ENSMUST00000026367.9
|
Sp4
|
trans-acting transcription factor 4 |
chr2_+_4017727 | 0.48 |
ENSMUST00000177457.1
|
Frmd4a
|
FERM domain containing 4A |
chr2_-_30415389 | 0.48 |
ENSMUST00000142096.1
|
Crat
|
carnitine acetyltransferase |
chr11_-_85139939 | 0.48 |
ENSMUST00000108075.2
|
Usp32
|
ubiquitin specific peptidase 32 |
chr16_+_95258036 | 0.48 |
ENSMUST00000113859.1
|
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr1_-_84839304 | 0.48 |
ENSMUST00000027421.6
|
Trip12
|
thyroid hormone receptor interactor 12 |
chr17_+_5799616 | 0.48 |
ENSMUST00000181392.1
|
3300005D01Rik
|
RIKEN cDNA 3300005D01 gene |
chr17_+_35077080 | 0.48 |
ENSMUST00000172959.1
|
Ly6g6e
|
lymphocyte antigen 6 complex, locus G6E |
chr11_+_96931387 | 0.48 |
ENSMUST00000107633.1
|
Prr15l
|
proline rich 15-like |
chr11_+_84179792 | 0.48 |
ENSMUST00000137500.2
ENSMUST00000130012.2 |
Acaca
|
acetyl-Coenzyme A carboxylase alpha |
chr3_-_30509462 | 0.47 |
ENSMUST00000173899.1
|
Mecom
|
MDS1 and EVI1 complex locus |
chr2_-_59160644 | 0.47 |
ENSMUST00000077687.5
|
Ccdc148
|
coiled-coil domain containing 148 |
chr1_+_75400070 | 0.47 |
ENSMUST00000113589.1
|
Speg
|
SPEG complex locus |
chr7_+_75610038 | 0.47 |
ENSMUST00000125771.1
|
Akap13
|
A kinase (PRKA) anchor protein 13 |
chr4_-_44167988 | 0.47 |
ENSMUST00000143337.1
|
Rnf38
|
ring finger protein 38 |
chr11_+_98203314 | 0.47 |
ENSMUST00000003203.7
ENSMUST00000107538.1 |
Cdk12
|
cyclin-dependent kinase 12 |
chr7_-_102210120 | 0.46 |
ENSMUST00000070165.5
|
Nup98
|
nucleoporin 98 |
chr13_+_96542602 | 0.46 |
ENSMUST00000179226.1
|
Col4a3bp
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
chr6_-_56362356 | 0.46 |
ENSMUST00000044505.7
ENSMUST00000166102.1 ENSMUST00000164037.1 ENSMUST00000114327.2 |
Pde1c
|
phosphodiesterase 1C |
chrX_-_70365052 | 0.46 |
ENSMUST00000101509.2
|
Ids
|
iduronate 2-sulfatase |
chr10_-_80657071 | 0.46 |
ENSMUST00000003434.7
|
Btbd2
|
BTB (POZ) domain containing 2 |
chrX_-_78583882 | 0.46 |
ENSMUST00000114025.1
ENSMUST00000134602.1 ENSMUST00000114024.2 |
Prrg1
|
proline rich Gla (G-carboxyglutamic acid) 1 |
chr16_+_56075399 | 0.46 |
ENSMUST00000089362.2
ENSMUST00000089360.3 ENSMUST00000049128.6 |
Senp7
|
SUMO1/sentrin specific peptidase 7 |
chrX_+_85574018 | 0.45 |
ENSMUST00000048250.3
ENSMUST00000137438.1 ENSMUST00000146063.1 |
Tab3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
chr12_+_95695350 | 0.45 |
ENSMUST00000110117.1
|
Flrt2
|
fibronectin leucine rich transmembrane protein 2 |
chr2_+_105127200 | 0.45 |
ENSMUST00000139585.1
|
Wt1
|
Wilms tumor 1 homolog |
chr5_-_45856496 | 0.45 |
ENSMUST00000087164.3
ENSMUST00000121573.1 |
Lcorl
|
ligand dependent nuclear receptor corepressor-like |
chr7_-_133123409 | 0.45 |
ENSMUST00000170459.1
ENSMUST00000166400.1 |
Ctbp2
|
C-terminal binding protein 2 |
chr6_-_77979515 | 0.45 |
ENSMUST00000159626.1
ENSMUST00000075340.5 ENSMUST00000162273.1 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr11_+_69765970 | 0.44 |
ENSMUST00000108642.1
ENSMUST00000156932.1 |
Zbtb4
|
zinc finger and BTB domain containing 4 |
chr6_-_122340499 | 0.44 |
ENSMUST00000160843.1
|
Phc1
|
polyhomeotic-like 1 (Drosophila) |
chr11_-_68386974 | 0.44 |
ENSMUST00000135141.1
|
Ntn1
|
netrin 1 |
chr11_+_84179852 | 0.44 |
ENSMUST00000136463.2
|
Acaca
|
acetyl-Coenzyme A carboxylase alpha |
chr13_+_93304066 | 0.43 |
ENSMUST00000109493.1
|
Homer1
|
homer homolog 1 (Drosophila) |
chr17_-_34121944 | 0.43 |
ENSMUST00000151986.1
|
Brd2
|
bromodomain containing 2 |
chr4_+_133176336 | 0.43 |
ENSMUST00000105912.1
|
Wasf2
|
WAS protein family, member 2 |
chr18_-_78206408 | 0.43 |
ENSMUST00000163367.1
|
Slc14a2
|
solute carrier family 14 (urea transporter), member 2 |
chr14_+_25459267 | 0.43 |
ENSMUST00000007961.8
|
Zmiz1
|
zinc finger, MIZ-type containing 1 |
chr14_-_34502522 | 0.43 |
ENSMUST00000171551.1
|
Bmpr1a
|
bone morphogenetic protein receptor, type 1A |
chr2_-_165884636 | 0.43 |
ENSMUST00000177633.1
ENSMUST00000018050.7 ENSMUST00000088113.4 |
Zmynd8
|
zinc finger, MYND-type containing 8 |
chr18_+_88971790 | 0.43 |
ENSMUST00000023828.7
|
Rttn
|
rotatin |
chr2_+_5951440 | 0.42 |
ENSMUST00000060092.6
|
Upf2
|
UPF2 regulator of nonsense transcripts homolog (yeast) |
chr4_-_44167905 | 0.42 |
ENSMUST00000102934.2
|
Rnf38
|
ring finger protein 38 |
chr19_+_44757394 | 0.42 |
ENSMUST00000004340.4
|
Pax2
|
paired box gene 2 |
chr12_+_3806513 | 0.42 |
ENSMUST00000172719.1
|
Dnmt3a
|
DNA methyltransferase 3A |
chrX_+_48108912 | 0.42 |
ENSMUST00000114998.1
ENSMUST00000115000.3 |
Xpnpep2
|
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
chr7_+_127876796 | 0.42 |
ENSMUST00000131000.1
|
Zfp646
|
zinc finger protein 646 |
chr10_-_81430966 | 0.42 |
ENSMUST00000117966.1
|
Nfic
|
nuclear factor I/C |
chr16_-_76373014 | 0.42 |
ENSMUST00000054178.1
|
Nrip1
|
nuclear receptor interacting protein 1 |
chr11_-_69758223 | 0.41 |
ENSMUST00000071213.3
|
Polr2a
|
polymerase (RNA) II (DNA directed) polypeptide A |
chrX_-_102251852 | 0.41 |
ENSMUST00000101336.3
ENSMUST00000136277.1 |
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr18_-_43393346 | 0.41 |
ENSMUST00000025379.7
|
Dpysl3
|
dihydropyrimidinase-like 3 |
chr14_+_55854115 | 0.40 |
ENSMUST00000168479.1
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr9_+_38719024 | 0.40 |
ENSMUST00000129598.1
|
Vwa5a
|
von Willebrand factor A domain containing 5A |
chr1_-_133801031 | 0.40 |
ENSMUST00000143567.1
|
Atp2b4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr4_+_101550411 | 0.40 |
ENSMUST00000094953.4
ENSMUST00000106933.1 |
Dnajc6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr4_-_132049058 | 0.40 |
ENSMUST00000105981.2
ENSMUST00000084253.3 ENSMUST00000141291.1 |
Epb4.1
|
erythrocyte protein band 4.1 |
chr10_-_30803075 | 0.40 |
ENSMUST00000068567.4
|
Ncoa7
|
nuclear receptor coactivator 7 |
chrX_-_136780141 | 0.40 |
ENSMUST00000018739.4
|
Glra4
|
glycine receptor, alpha 4 subunit |
chr11_+_23306910 | 0.39 |
ENSMUST00000137823.1
|
Usp34
|
ubiquitin specific peptidase 34 |
chr11_+_24078173 | 0.39 |
ENSMUST00000109514.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr11_-_116077927 | 0.39 |
ENSMUST00000156545.1
|
Unc13d
|
unc-13 homolog D (C. elegans) |
chr7_+_140093388 | 0.39 |
ENSMUST00000026540.8
|
Prap1
|
proline-rich acidic protein 1 |
chr15_-_82912134 | 0.39 |
ENSMUST00000048966.5
ENSMUST00000109510.2 |
Tcf20
|
transcription factor 20 |
chr19_-_28010995 | 0.39 |
ENSMUST00000172907.1
ENSMUST00000046898.9 |
Rfx3
|
regulatory factor X, 3 (influences HLA class II expression) |
chr2_+_18064564 | 0.39 |
ENSMUST00000114671.1
|
Mllt10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
chr18_+_8694077 | 0.39 |
ENSMUST00000171469.1
|
Gm5819
|
predicted gene 5819 |
chr7_-_46795661 | 0.39 |
ENSMUST00000123725.1
|
Hps5
|
Hermansky-Pudlak syndrome 5 homolog (human) |
chr15_-_102624922 | 0.39 |
ENSMUST00000183765.1
|
ATF7
|
Cyclic AMP-dependent transcription factor ATF-7 |
chr9_-_44721383 | 0.38 |
ENSMUST00000148929.1
ENSMUST00000123406.1 |
Phldb1
|
pleckstrin homology-like domain, family B, member 1 |
chr2_+_74711911 | 0.38 |
ENSMUST00000111983.2
|
Hoxd3
|
homeobox D3 |
chr11_+_96251100 | 0.38 |
ENSMUST00000129907.2
|
Gm53
|
predicted gene 53 |
chr6_+_128399766 | 0.38 |
ENSMUST00000001561.5
|
Nrip2
|
nuclear receptor interacting protein 2 |
chr1_-_160792908 | 0.38 |
ENSMUST00000028049.7
|
Rabgap1l
|
RAB GTPase activating protein 1-like |
chr3_+_108085976 | 0.38 |
ENSMUST00000070502.1
|
Gm12500
|
predicted gene 12500 |
chr16_-_22439570 | 0.38 |
ENSMUST00000170393.1
|
Etv5
|
ets variant gene 5 |
chr10_+_42583787 | 0.38 |
ENSMUST00000105497.1
ENSMUST00000144806.1 |
Ostm1
|
osteopetrosis associated transmembrane protein 1 |
chr17_-_26199008 | 0.38 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr4_+_108460000 | 0.38 |
ENSMUST00000097925.2
|
Zcchc11
|
zinc finger, CCHC domain containing 11 |
chr1_-_168432270 | 0.38 |
ENSMUST00000072863.4
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr1_+_172341197 | 0.37 |
ENSMUST00000056136.3
|
Kcnj10
|
potassium inwardly-rectifying channel, subfamily J, member 10 |
chr19_+_27217011 | 0.37 |
ENSMUST00000164746.1
ENSMUST00000172302.1 |
Vldlr
|
very low density lipoprotein receptor |
chr15_-_102366314 | 0.37 |
ENSMUST00000078508.5
|
Sp7
|
Sp7 transcription factor 7 |
chr6_+_87428986 | 0.37 |
ENSMUST00000032125.5
|
Bmp10
|
bone morphogenetic protein 10 |
chr3_-_79567771 | 0.37 |
ENSMUST00000133154.1
|
Fnip2
|
folliculin interacting protein 2 |
chr11_-_108343917 | 0.37 |
ENSMUST00000059595.4
|
Prkca
|
protein kinase C, alpha |
chr6_+_128399881 | 0.37 |
ENSMUST00000120405.1
|
Nrip2
|
nuclear receptor interacting protein 2 |
chr14_+_64652524 | 0.37 |
ENSMUST00000100473.4
|
Kif13b
|
kinesin family member 13B |
chr17_+_48346401 | 0.37 |
ENSMUST00000024791.8
|
Trem2
|
triggering receptor expressed on myeloid cells 2 |
chr11_-_9011111 | 0.37 |
ENSMUST00000020683.3
|
Hus1
|
Hus1 homolog (S. pombe) |
chr1_-_132067826 | 0.37 |
ENSMUST00000160656.1
ENSMUST00000161864.1 ENSMUST00000126927.1 ENSMUST00000159038.1 |
Mfsd4
|
major facilitator superfamily domain containing 4 |
chr5_-_73256555 | 0.37 |
ENSMUST00000171179.1
ENSMUST00000101127.5 |
Fryl
Fryl
|
furry homolog-like (Drosophila) furry homolog-like (Drosophila) |
chrX_-_105929206 | 0.37 |
ENSMUST00000134381.1
ENSMUST00000154866.1 |
Atrx
|
alpha thalassemia/mental retardation syndrome X-linked homolog (human) |
chr10_+_108162358 | 0.37 |
ENSMUST00000070663.5
|
Ppp1r12a
|
protein phosphatase 1, regulatory (inhibitor) subunit 12A |
chr14_-_64949632 | 0.37 |
ENSMUST00000176832.1
|
Hmbox1
|
homeobox containing 1 |
chr6_+_17463826 | 0.36 |
ENSMUST00000140070.1
|
Met
|
met proto-oncogene |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.8 | 3.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.5 | 2.4 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 1.2 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.4 | 1.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.4 | 1.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.4 | 1.1 | GO:1904980 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.3 | 1.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.3 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) |
0.3 | 0.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 1.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.3 | 0.8 | GO:2000979 | hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.3 | 1.0 | GO:0003360 | brainstem development(GO:0003360) |
0.3 | 0.8 | GO:2000597 | optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.3 | 1.0 | GO:0035128 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.2 | 1.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 0.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 0.9 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 0.2 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.2 | 0.2 | GO:0099404 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.2 | 1.7 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 0.6 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.2 | 1.4 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.2 | 0.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.2 | 1.0 | GO:0071104 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
0.2 | 0.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.6 | GO:0072004 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) |
0.2 | 0.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 0.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.7 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.2 | 1.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 1.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 1.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.7 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
0.2 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.2 | 0.2 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.2 | 1.8 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 1.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.5 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 0.3 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
0.2 | 0.5 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.7 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.6 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.4 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.4 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.1 | 0.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.4 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 | 0.5 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 1.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 0.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 1.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 1.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.1 | 0.8 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.1 | 0.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 1.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.3 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.4 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 | 4.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 1.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.2 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.8 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.1 | 0.3 | GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.1 | 0.3 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.4 | GO:0060032 | notochord regression(GO:0060032) |
0.1 | 0.4 | GO:2000705 | negative regulation of anion channel activity(GO:0010360) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.4 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.1 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.1 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.3 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.1 | 0.4 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.4 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.3 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.1 | 1.0 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 1.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.1 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
0.1 | 0.3 | GO:0030221 | basophil differentiation(GO:0030221) |
0.1 | 0.2 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
0.1 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 1.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.7 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.6 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.1 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.1 | 0.3 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 0.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.7 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.1 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.1 | 0.2 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.1 | 0.2 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.1 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.1 | 0.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.2 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.1 | 0.1 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 | 0.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.8 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.1 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.1 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.1 | 0.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.3 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.1 | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.1 | 0.3 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 1.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.2 | GO:0045041 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 1.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.2 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 1.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.2 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.1 | 0.2 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.1 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) telomerase RNA stabilization(GO:0090669) |
0.1 | 0.2 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.3 | GO:0039536 | regulation of RIG-I signaling pathway(GO:0039535) negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.1 | 0.3 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.1 | 0.1 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
0.1 | 0.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.2 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.1 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.1 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.1 | 0.3 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
0.1 | 1.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.0 | 0.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.0 | 0.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.0 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.3 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.1 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.0 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.0 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.0 | 0.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.1 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:0009726 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.0 | 0.4 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.0 | 0.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.0 | 0.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.2 | GO:0035993 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) superior vena cava morphogenesis(GO:0060578) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.1 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.0 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.0 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.2 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.3 | GO:0099633 | protein localization to postsynaptic specialization membrane(GO:0099633) neurotransmitter receptor localization to postsynaptic specialization membrane(GO:0099645) |
0.0 | 0.9 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.1 | GO:0009804 | coumarin metabolic process(GO:0009804) dibenzo-p-dioxin metabolic process(GO:0018894) |
0.0 | 0.4 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.2 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) |
0.0 | 0.4 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.6 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 1.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 1.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.0 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.0 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.7 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.0 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.0 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0003195 | tricuspid valve formation(GO:0003195) |
0.0 | 0.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.0 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) monocyte extravasation(GO:0035696) interleukin-15-mediated signaling pathway(GO:0035723) activation of meiosis involved in egg activation(GO:0060466) cellular response to interleukin-15(GO:0071350) response to fluoride(GO:1902617) regulation of monocyte extravasation(GO:2000437) |
0.0 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 1.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.5 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.1 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.0 | 0.0 | GO:0072284 | comma-shaped body morphogenesis(GO:0072049) metanephric S-shaped body morphogenesis(GO:0072284) |
0.0 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 1.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.0 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.0 | 0.3 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.0 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.0 | 0.3 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.5 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:0051794 | regulation of catagen(GO:0051794) |
0.0 | 0.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 0.3 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.0 | 0.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.1 | GO:0097252 | negative regulation of interleukin-13 production(GO:0032696) oligodendrocyte apoptotic process(GO:0097252) |
0.0 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.0 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.0 | 0.1 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 | 0.1 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.3 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.0 | 0.2 | GO:1905206 | positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.0 | 0.1 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
0.0 | 0.1 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.0 | 0.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.0 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:1990839 | response to endothelin(GO:1990839) |
0.0 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.2 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.0 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.0 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.0 | 0.1 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.1 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.0 | 0.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.0 | 0.0 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.0 | 0.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.0 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.1 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
0.0 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.0 | GO:2000293 | regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.0 | 0.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.6 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.0 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.0 | 0.1 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.1 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.0 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.0 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.0 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
0.0 | 0.1 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.0 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 1.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.0 | 0.0 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.9 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.1 | GO:0061072 | voluntary musculoskeletal movement(GO:0050882) iris morphogenesis(GO:0061072) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.3 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.1 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 1.0 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 1.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.0 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.3 | GO:0050913 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.0 | 0.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.0 | GO:0042796 | snRNA transcription from RNA polymerase II promoter(GO:0042795) snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:1904587 | response to glycoprotein(GO:1904587) |
0.0 | 0.4 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.0 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.0 | 0.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.0 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.2 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:0090070 |